Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 2Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Kidney Failure, Chronic 1Endometrial Neoplasms 1End Stage Liver Disease 1Death 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Nivolumab 5pembrolizumab 4Ipilimumab 2Drug Therapy 2Biopsy 2poly ICLC 1pertuzumab 1osimertinib 1montanide ISA 51 1liposomal doxorubicin 1flt3 ligand protein 1cobimetinib 1cemiplimab 1cc-486 1brodalumab 1Trastuzumab 1Tissue Banks 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Quality of Life 1Psychiatric Rehabilitation 1Poly I-C 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Mass Screening × Genitourinary × Clear all
NCT00859768 2011-03-08

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Netherlands Open University

Phase NA Completed
568 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡